Frank Kalkbrenner
MEMBER
pediatric
Hookipa Biotech
Austria
Biography
Dr. Frank Kalkbrenner is Managing Director of the Boehringer Ingelheim Corporate Venture Fund. He serves as Board member of STAT Diagnostica in Barcelona, Eyevensis in Paris, and as interim CEO and Board member of Acousia Therapeutics in Tübingen. Dr. Kalkbrenner is also a member of the supervisory and the Advisory Board of Inserm Transfer Initiative, a French Seed Investment Fund based in Paris.
Research Interest
Pediatric & Neonatal Health care, Vaccination
